Effects of Lenvatinib combined with immune checkpoint inhibitors on efficacy, immune function and prognosis in patients with primary liver cancer
Lenvatinib combined with immune checkpoint inhibitors can significantly improve the objective response rate in patients with advanced liver cancer, enhance their immune function and improve their quality of life, demonstrating satisfactory safety.
Institutions
- Hebei Medical University (CN)
- Beijing Institute of Water (CN)
- First Hospital of Shijiazhuang (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-11-26
- DOI
- https://doi.org/10.12669/pjms.41.12.12763
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00